Nuestro grupo organiza más de 3000 Series de conferencias Eventos cada año en EE. UU., Europa y América. Asia con el apoyo de 1.000 sociedades científicas más y publica más de 700 Acceso abierto Revistas que contienen más de 50.000 personalidades eminentes, científicos de renombre como miembros del consejo editorial.
Revistas de acceso abierto que ganan más lectores y citas
700 revistas y 15 000 000 de lectores Cada revista obtiene más de 25 000 lectores
Radhey Srivastava
C. albicans and Aspergillus fumigatus are the two most frequent fungi that cause severe, undetectable infections in impaired persons. Fluconazole is a highly bioavailable antifungal medication of the triazole class. This study uses Aspergillus fumigatus and Candida albicans to examine the biological effects of fluconazole in both its natural form and as a micronized powder. Using the Microniser, an antifungal active medicinal component was reduced to its tiniest feasible particle size. The antifungal effectiveness of the product was contrasted between the plain material (heavy molecules, 200 microns in diameter), and smaller molecules, 2.72 microns in diameter. Antifungal drugs work best when the particles are the tiniest. The properties and particle size of the micronized material (extremely fine powder) are studied by SEM, Fourier transform infrared spectroscopy (FT-IR), and laser diffraction. The antifungal activity of micronized fluconazole is more effective than that of fluconazole plain material (coarser type particles).